IKK/NF-κB signaling: balancing life and death -: a new approach to cancer therapy

被引:725
作者
Luo, JL [1 ]
Kamata, H [1 ]
Karin, M [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol & Canc Ctr, La Jolla, CA 92093 USA
关键词
D O I
10.1172/JCI26322
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1KB kinase/NF-KB (IkK/NF-KB) signaling pathways play critical roles in a variety of physiological and pathological processes. One function of NF-KB is promotion of cell survival through induction of target genes, whose products inhibit components of the apoptotic machinery in normal and cancerous cells. NF-KB can also prevent programmed necrosis by inducing genes encoding antioxidant proteins. Regardless of mechanism, many cancer cells, of either epithelial or hematopoietic origin. use NF-KB to achieve resistance to anticancer drugs, radiation, and death cytokines. Hence, inhibition of IKK-driven NF-KB activation offers a strategy for treatment of different malignancies and can convert inflammation-induced tumor growth to inflammation-induced tumor regression.
引用
收藏
页码:2625 / 2632
页数:8
相关论文
共 119 条
[1]   Death without caspases, caspases without death [J].
Abraham, MC ;
Shaham, S .
TRENDS IN CELL BIOLOGY, 2004, 14 (04) :184-193
[2]   Cell signalling (communication arising) - Cell survival and a Gadd45-factor deficiency [J].
Amanullah, A ;
Azam, N ;
Balliet, A ;
Hollander, C ;
Hoffman, B ;
Fornace, A ;
Liebermann, D .
NATURE, 2003, 424 (6950) :741-742
[3]   TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling [J].
Becker, C ;
Fantini, MC ;
Schramm, C ;
Lehr, HA ;
Wirtz, S ;
Nikolaev, A ;
Burg, J ;
Strand, S ;
Kiesslich, R ;
Huber, S ;
Ito, H ;
Nishimoto, N ;
Yoshizaki, K ;
Nishimoto, N ;
Galle, PR ;
Blessing, M ;
Rose-John, S ;
Neurath, MF .
IMMUNITY, 2004, 21 (04) :491-501
[4]   EMBRYONIC LETHALITY AND LIVER DEGENERATION IN MICE LACKING THE RELA COMPONENT OF NF-KAPPA-B [J].
BEG, AA ;
SHA, WC ;
BRONSON, RT ;
GHOSH, S ;
BALTIMORE, D .
NATURE, 1995, 376 (6536) :167-170
[5]   BRCA1 augments transcription by the NF-κB transcription factor by binding to the rel domain of the p65/RelA subunit [J].
Benezra, M ;
Chevallier, N ;
Morrison, DJ ;
MacLachlan, TK ;
El-Deiry, WS ;
Licht, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (29) :26333-26341
[6]   PYRROLIDINE DITHIOCARBAMATE, A POTENT INHIBITOR OF NUCLEAR FACTOR KAPPA-B (NF-KAPPA-B) ACTIVATION, PREVENTS APOPTOSIS IN HUMAN PROMYELOCYTIC LEUKEMIA HL-60 CELLS AND THYMOCYTES [J].
BESSHO, R ;
MATSUBARA, K ;
KUBOTA, M ;
KUWAKADO, K ;
HIROTA, H ;
WAKAZONO, Y ;
LIN, YW ;
OKUDA, A ;
KAWAI, M ;
NISHIKOMORI, R ;
HEIKE, T .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (10) :1883-1889
[7]   NF-κB activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells [J].
Bian, X ;
McAllister-Lucas, LM ;
Shao, F ;
Schumacher, KR ;
Feng, ZW ;
Porter, AG ;
Castle, VP ;
Opipari, AW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) :48921-48929
[8]   p53 induces NF-κB activation by an IκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1 [J].
Bohuslav, J ;
Chen, LF ;
Kwon, H ;
Mu, YJ ;
Greene, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (25) :26115-26125
[9]   The two NF-κB activation pathways and their role in innate and adaptive immunity [J].
Bonizzi, G ;
Karin, M .
TRENDS IN IMMUNOLOGY, 2004, 25 (06) :280-288
[10]   Active repression of antiapoptotic gene expression by ReIA(p65) NF-κB [J].
Campbell, KJ ;
Rocha, S ;
Perkins, ND .
MOLECULAR CELL, 2004, 13 (06) :853-865